(19)
(11) EP 1 631 311 A2

(12)

(88) Date of publication A3:
22.12.2005

(43) Date of publication:
08.03.2006 Bulletin 2006/10

(21) Application number: 03819151.6

(22) Date of filing: 10.12.2003
(51) International Patent Classification (IPC): 
A61K 39/395(1985.01)
(86) International application number:
PCT/US2003/039599
(87) International publication number:
WO 2005/060368 (07.07.2005 Gazette 2005/27)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(71) Applicant: MILLENNIUM PHARMACEUTICALS, INC.
Cambridge, MA 02139-4169 (US)

(72) Inventors:
  • O'KEEFE, Theresa
    Waltham, MA 02453 (US)
  • PONATH, Paul
    San Francisco, CA 94114 (US)

(74) Representative: Williams, Gareth Owen 
Marks & Clerk 66-68 Hills Road
Cambridge CB2 1LA
Cambridge CB2 1LA (GB)

   


(54) HUMANIZED ANTI-CCR2 ANTIBODIES AND METHODS OF USE